Prices are closing data as of 2026-11-09, not real-time quotes. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for INSMED Inc?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2016–2025
Key Multi-Year Facts
- Net income was negative in FY2016, FY2017, FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024, FY2025.
Latest 5 Fiscal Years
| Fiscal Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (USD B) | 0.19 | 0.25 | 0.31 | 0.36 | 0.61 |
| YoY | 14.6% | 30.2% | 24.4% | 19.2% | 66.7% |
| Net Income (USD B) | -0.43 | -0.48 | -0.75 | -0.91 | -1.28 |
| Operating Cash Flow (USD B) | -0.36 | -0.40 | -0.54 | -0.68 | -0.94 |
| ROE | -126.7% | -193.2% | — | -320.2% | -249.3% |
| Gross Margin | 76.6% | 77.5% | 78.5% | 76.4% | 79.7% |
| Net Margin | -230.6% | -196.3% | -245.6% | -251.2% | -210.5% |
| Debt-to-Assets | 67.0% | 94.7% | 125.0% | 85.9% | 67.4% |
Show all 10 fiscal years
| Fiscal Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD B) | 0.00 | 0.00 | 0.01 | 0.14 | 0.16 | 0.19 | 0.25 | 0.31 | 0.36 | 0.61 |
| YoY | — | — | — | 1287.6% | 20.5% | 14.6% | 30.2% | 24.4% | 19.2% | 66.7% |
| Net Income (USD B) | -0.18 | -0.19 | -0.32 | -0.25 | -0.29 | -0.43 | -0.48 | -0.75 | -0.91 | -1.28 |
| Operating Cash Flow (USD B) | -0.15 | -0.16 | -0.26 | -0.25 | -0.22 | -0.36 | -0.40 | -0.54 | -0.68 | -0.94 |
| ROE | -114.1% | -74.7% | -113.9% | -108.2% | -109.4% | -126.7% | -193.2% | — | -320.2% | -249.3% |
| Gross Margin | — | — | 75.4% | 82.3% | 75.7% | 76.6% | 77.5% | 78.5% | 76.4% | 79.7% |
| Net Margin | — | — | -3297.2% | -186.4% | -178.9% | -230.6% | -196.3% | -245.6% | -251.2% | -210.5% |
| Debt-to-Assets | 35.1% | 21.9% | 65.6% | 64.7% | 65.3% | 67.0% | 94.7% | 125.0% | 85.9% | 67.4% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: SEC XBRL filings, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-10
Rules-based screening using SEC XBRL financial data and 8-K/NT material event filings (no AI opinions).
Items Flagged for Review
-
Alert
Receivables DaysFinancial Quality
84.8 days, prior FY 52.2 days(+62%)
FY2025 (ended 2025-12-31) · What is this?
- Alert
-
Alert
Net LossesGoing Concern
FY2025 (2025-12-31) $-1.28B, FY2024 (2024-12-31) $-0.91B
FY2025 (ended 2025-12-31)
- Watch
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
More U.S. data: 500 largest U.S. companies · U.S. high dividend stocks · Is the stock market open today?
Compiled mechanically from public filings and market quotes (data as of 2026-11-10). For informational purposes only, not investment advice.